| Literature DB >> 33964239 |
Rachael Lappan1, Rebekah Henry2, Steven L Chown3, Stephen P Luby4, Ellen E Higginson5, Lamiya Bata2, Thanavit Jirapanjawat1, Christelle Schang6, John J Openshaw4, Joanne O'Toole7, Audrie Lin8, Autiko Tela9, Amelia Turagabeci9, Tony H F Wong10, Matthew A French11, Rebekah R Brown11, Karin Leder7, Chris Greening1, David McCarthy12.
Abstract
BACKGROUND: Multiple bacteria, viruses, protists, and helminths cause enteric infections that greatly impact human health and wellbeing. These enteropathogens are transmited via several pathways through human, animal, and environmental reservoirs. Individual qPCR assays have been extensively used to detect enteropathogens within these types of samples, whereas the TaqMan array card (TAC), which allows simultaneous detection of multiple enteropathogens, has only previously been validated in human clinical samples.Entities:
Year: 2021 PMID: 33964239 PMCID: PMC8116308 DOI: 10.1016/S2542-5196(21)00051-6
Source DB: PubMed Journal: Lancet Planet Health ISSN: 2542-5196
TaqMan qPCR assays used for detection by standard qPCR and custom TaqMan array cards
| CTGCTAAACCATAGAAATAAAATTTCTCAC | CTTTGAAGGTAATTTAGATATGGATAATCG | 5’HEX-CATTTTGACGATTTTTGGCTTGA-3’MGB | ||
| TCGGGCAATTCGTTATTGG | GATAAACTGGACCACGGTGACA | 5’FAM-AAGACAACAAAACCCACCGC-3’MGB | ||
| STEC | ACTTCTCGACTGCAAAGACGTATG | ACAAATTATCCCCTGWGCCACTATC | 5’Texas Red-CTCTGCAATAGGTACTCCA-3’MGB | |
| STEC | CCACATCGGTGTCTGTTATTAACC | GGTCAAAACGCGCCTGATAG | 5’FAM-TTGCTGTGGATATACGAGG-3’MGB | |
| EPEC | CATTGATCAGGATTTTTCTGGTGATA | CTCATGCGGAAATAGCCGTTA | 5’FAM-ATACTGGCGAGACTATTTCAA-3’MGB | |
| 18S rRNA | GGGTTGTATTTATTAGATAAAGAACCA | AGGCCAATACCCTACCGTCT | 5’FAM-TGACATATCATTCAAGTTTCTGAC-3’MGB | |
| 18S rRNA | GACGGCTCAGGACAACGGTT | TTGCCAGCGGTGTCCG | 5’HEX-CCCGCGGCGGTCCCTGCTAG-3’MGB | |
| 16S rRNA | ATCATGAGTTCACATGTCCG | CTTCCTCTCAGAACCCCTATCC | 5’FAM-CTAATGGAACGCATCCC-3’MGB | |
| Internal amplification control | 16S rRNA | ATCATGAGTTCACATGTCCG | CTTCCTCTCAGAACCCCTATCC | 5’VIC-AACACGCCGTTGCTACA-3’MGB |
The following assays were multiplexed: cadF and invA; Giardia and Cryptosporidium; Bacteroides and the internal amplification control; stx1 and stx2. The eae assay was run singleplex. Prior to the use of multiplex assays, standard curves were generated for the singleplex and multiplex formats and evaluated to confirm the absence of cross-target amplification or inhibition. STEC=Shiga toxin-producing Escherichia coli. EPEC=enteropathogenic Escherichia coli.
TaqMan array card probes were identical with the exception of the fluorophore (all TAC probes were 5’FAM 3’MGB).
The internal amplification control targets Bacteroides and was applied to standalone qPCR assays only.
Figure 1Quantitation of spiked genetic material in nuclease-free water by TAC and standard qPCR
Ten different combinations of spiked material were tested in a randomised double-blinded manner. Figure shows samples spiked randomly in different combinations (samples 1, 3, 4, 6, 9, 10); those spiked at consistent concentrations of 10 copies per μL (sample 7), 100 copies per μL (sample 2), or 1000 copies per μL (sample 8); or not spiked at all (sample 5; a blank control). For each target, the quantity of material spiked (white circle), the copies detected by standard qPCR (blue circle), and the copies detected by TAC (yellow circle) are shown. TAC=TaqMan array card. EPEC=enteropathogenic Escherichia coli. STEC=Shiga toxin-producing Escherichia coli.
Performance of TAC and qPCR on spiked samples in sample matrices varying in levels of PCR inhibitors
| TAC | qPCR | TAC | qPCR | |
|---|---|---|---|---|
| Nuclease-free water | 92% (59/64) | 100% (64/64) | 91% (73/80) | 99% (79/80) |
| Creek water | 93% (28/30) | 97% (29/30) | 80% (16/20) | 80% (16/20) |
| Sediment | 60% (18/30) | 57% (17/30) | 43% (17/40) | 30% (12/40) |
| Human stool | 83% (25/30) | 97% (29/30) | 80% (24/30) | 90% (27/30) |
| Fluorinated potable water | 71% (40/56) | 95% (53/56) | 63% (35/56) | 73% (41/56) |
| Extraction blank | 83% (25/30) | 97% (29/30) | 80% (32/40) | 83% (33/40) |
| 85% (23/27) | 85% (23/27) | 82% (22/27) | 85% (23/27) | |
| 77% (24/31) | 87% (27/31) | 49% (18/37) | 78% (29/37) | |
| 77% (24/31) | 90% (28/31) | 70% (26/37) | 54% (20/37) | |
| EPEC ( | 74% (23/31) | 90% (28/31) | 73% (27/37) | 78% (29/37) |
| 90% (28/31) | 97% (30/31) | 82% (22/27) | 82% (22/27) | |
| 84% (26/31) | 97% (30/31) | 78% (25/32) | 69% (22/32) | |
| STEC ( | 85% (23/27) | 96% (26/27) | 88% (28/32) | 91% (29/32) |
| STEC ( | 77% (24/31) | 94% (29/31) | 78% (29/37) | 92% (34/37) |
Data are % (n/N). Results are shown by sample matrix and by target. Sensitivity is defined as the percentage of spiked targets that were detected. Accuracy is measured as percentage of assays within one log10 of the spiked concentration; assays where background levels of pathogen were detected by qPCR or TAC are excluded from these calculations (20 creek water assays and ten human stool assays excluded). TAC=TaqMan array card. STEC=Shiga toxin-producing Escherichia coli. EPEC=enteropathogenic Escherichia coli.
Figure 2Concordance between standard qPCR and TAC in detecting pathogens in animal scats, child stool, soil, and water collected from informal settlements of Suva, Fiji
Agreement between the methods with respect to the number of positive detections of targets (A) and the measured target quantity in log10 gene copies per μL of extracted DNA (with a pseudocount of 1 added before log10 transformation; (B). The regression lines with associated 95% CIs are shown for the subset of data where a target was quantified by both methods (blue, R2 0·815). Across all datapoints, R2 0·668 (grey). TAC=TaqMan array card. EPEC=enteropathogenic Escherichia coli. STEC=Shiga toxin-producing Escherichia coli.
Figure 3Pathogen and indicator targets detected via TAC in Melbourne wastewater samples and animal scats, child stool, soil, and water collected from informal settlements of Suva, Fiji
Heatmaps represent the prevalence (percentage of positive samples [A]) and abundance (mean value of log10 gene copies per ng of DNA across positive samples [B]) of each target by sample type. White represents a zero value, and 18S rRNA quantitation was unavailable. The number of pathogens or indicators detected per sample is represented by histograms (C), also by sample type. This excludes the 16S rRNA and 18S rRNA targets and counts pathogens with multiple gene targets (ie, Campylobacter spp, Shigella spp, EAEC, ETEC, STEC, EPEC and Entamoeba spp) only once. TAC=TaqMan array card. EAEC=enteroaggregative Escherichia coli. ETEC=enterotoxigenic Escherichia coli. STEC=Shiga toxin-producing Escherichia coli. EPEC=enteropathogenic Escherichia coli.
Comparison of TAC and qPCR for monitoring multiple pathogens
| Target range | Narrow; individually detects any target of interest with appropriately optimised primers or probes; however, adding additional targets requires extra sample volume, labour, cost, and plastic waste; assays can be multiplexed (detection of multiple targets in one reaction) with careful optimisation | Broad; simultaneously detects up to 47 singleplex targets and 1 internal control across 8 samples; wells can be multiplexed or samples can be reduced to increase target number; assays require careful card design and manufacture with appropriate lead-time; optimisation may be required for target quantitation under universal conditions on the card |
| Sensitivity, accuracy | High sensitivity and accuracy; theoretical detection limit is approximately three gene copies per reaction; pathogen quantitation possible with appropriate reference standards; PCR inhibition possible, but can be readily monitored with controls | High sensitivity, medium accuracy; sensitivity high but often lower than qPCR given smaller reaction volume and universal reaction conditions; pathogen quantitation possible with reference standards, but generally requires comparisons between cards and typically a positive control plasmid containing multiple primer and probe sequences in tandem; quantitation also challenging due to co-detection of DNA and RNA due to universal reverse transcriptase step to detect RNA viruses; greater potential for PCR inhibition |
| Specificity | High; well designed TaqMan primer and probe sequences are very specific | High; same TaqMan technology as standard qPCR |
| Scalability | Moderate; extensive manual handling with large numbers of samples or pathogens; large sample numbers require high labour time or robotics; increased sample numbers require greater sample volume and produce more waste; high potential for pipetting errors | High; simple and moderately fast (approximately 3 h) to prepare and run from extracted nucleic acids; labour time is minimal given the few manual handling tasks required, though increases per card (eight samples); low potential for pipetting errors |
| Flexibility | High; given assays are run individually, targets can be changed at any time; reaction conditions can be modified to optimise amplification of each target | Low; a new set of cards must be manufactured and validated to add or change targets; the same reaction conditions must be used for each target |
| Cost | Low cost per sample; low reagent cost per sample (approximately US$2·10 for one pathogen without replicates); small cost increase with more samples, but large increase with more targets (double the labour and reagents cost for two targets); high upfront cost of real-time thermal cycler | Low cost per pathogen; moderate reagent cost per sample (approximately US$60); however, highly cost-effective for monitoring multiple targets per sample (approximately US$1·28 per sample per target without replicates); high upfront cost of real-time thermal cycler with array card block |
| Resources | Moderate; requires real-time thermal cycler; training for molecular biology, equipment use, and software required | Moderate; requires real-time thermal cycler with array card block; training needed for molecular biology, equipment, and software |
RT-qPCR=reverse transcriptase qPCR. TAC=TaqMan array cards.